News

Mimesis recently participated in the XV Forum della Borsa della Ricerca an annual national event that brings together a diverse array of stakeholders, including businesses, investors, universities, spin-offs, startups, research groups, and centers. This year’s forum, co-organized with the University of Catania and the Sicilian Region, was held at the historic Monastero dei Benedettini from October 21 to 23, 2024. A standout moment for Mimesis was the pitch presentation delivered by Martina Di Salvatore. During this session, she effectively showcased our innovative solutions in computational medicine, demonstrating how Mimesis leverages advanced computational models to simulate immune responses and address various health challenges. The unique format of the forum included One-to-One meetings that allowed delegates to connect based on mutual interests and needs. Two weeks before the event, participants could access a preview of all attendees and schedule meetings accordingly. This personalized approach resulted in numerous productive encounters with a wide array of companies, fostering valuable discussions on potential partnerships and collaborations. In addition to Mimesis’s contributions, the forum featured an array of engaging sessions and workshops, including a plenary session with institutional greetings from notable figures such as Francesco Priolo, Rector of the University of Catania, and Edmondo Tamajo, Regional Councillor for Productive Activities. The forum also hosted specialized events like the CrossRoads NODES and CrossRoads Samothrace, focusing on sectors such as agroindustry and life sciences, as well as various workshops dedicated to quantum technologies and innovative business development. The final day included a Pitch Session, where startups and spin-offs had the opportunity to present their ideas to a broader audience, culminating in the prestigious BdR Awards. Mimesis’s active engagement in this forum underscores our commitment to fostering innovation and collaboration in the realm of computational medicine. As we look forward to the future, Mimesis remains dedicated to driving advancements in healthcare through cutting-edge technology and strategic partnerships, contributing to the vibrant ecosystem of research and development in Sicily.

Catania, October 24, 2024 – Mimesis proudly participated in a significant event organized by the Observatory on Trends and Applications of Supercomputing. This gathering aimed to explore the transformative potential of supercomputing and its implications for the healthcare sector, particularly in computational medicine. Representing Mimesis, Martina Di Salvatore emphasized the critical role that advanced computational resources play in the field of in silico medicine. Mimesis, as a spin-off of the University of Catania, is dedicated to offering innovative solutions for the biomedical and pharmaceutical industries. Through the use of computational models, the company simulates the immune system’s behavior, enabling accurate responses in the context of various health challenges and therapies. Professor Francesco Pappalardo, a key figure in the company and co-leader of Spoke 8 ‘In Silico Medicine and Omics Data’ at the ICSC, highlighted how “in silico medicine is revolutionizing the research and development of new treatments, reducing drug development times and improving the precision of therapeutic interventions.” The event also featured the participation of other promising spin-offs from the University of Catania, as well as notable institutions like Ospedale Cannizzaro, showcasing the vibrant entrepreneurial ecosystem in the region. These organizations are leveraging advanced technologies to contribute to various sectors, highlighting the synergy between academic research and industry innovation. The gathering underscored the growing demand for supercomputing services, with projections indicating a significant increase in need by 2030. This surge presents substantial opportunities for companies that can harness advanced computational tools to drive innovation and enhance healthcare outcomes. As Mimesis continues to push the boundaries of computational medicine, it plays a vital role in shaping the future of healthcare in the region. The company is committed to advancing personalized medicine, aiming to streamline drug development processes and improve the precision of therapeutic interventions, ultimately benefiting patients and healthcare providers alike.

The In Silico World final event at the VPH2024 conference in Stuttgart was a landmark occasion, and the Mimesis group is thrilled to have been a key part of this groundbreaking event. With over 180 participants joining us both in person and virtually, the event provided a valuable platform to celebrate the advancements in #InSilicoMedicine and the collaborative achievements of our community. A standout moment of the conference was Prof. Pappalardo’s presentation, where he addressed the regulatory challenges facing in silico medicine and highlighted the significant progress made in navigating these barriers. His insights were instrumental in framing the current landscape and future directions for regulatory practices in our field. The Mimesis group was honored to showcase our innovative solutions and technological advancements, which represent the forefront of computational modeling and simulation in healthcare. Our work, presented alongside the COmbine group’s contributions, reflects the high level of innovation and dedication that has characterized the In Silico World project. Together, we are pioneering approaches that have the potential to revolutionize patient care through advanced predictive models and virtual simulations. We extend our deepest gratitude to all participants, contributors, and supporters who made this event a success. The collective effort and passion demonstrated by everyone involved have been truly inspiring. As we conclude the In Silico World project, we remain steadfast in our commitment to advancing #InSilicoMedicine and driving innovation in healthcare. At Mimesis, we are excited about the future and eager to continue pushing the boundaries of what’s possible in computational medicine. Our dedication to improving patient outcomes through innovative technologies will guide our efforts moving forward. We look forward to sharing more updates and continuing our journey toward transforming healthcare. Thank you to everyone who has been a part of this incredible endeavor. The future of in silico medicine is bright, and we are excited to continue this journey with our talented partners and the broader scientific community. Stay connected with Mimesis for more news and updates on our latest advancements in #InSilicoMedicine.

Ieri, 11 luglio 2024, si è tenuto l’evento 🌟 𝐏𝐢𝐚𝐜𝐞𝐫𝐢 𝐃𝐚𝐲 𝟐𝟎𝟐𝟒 🌟, una giornata dedicata alla ricerca promossa dall’Università degli Studi di Catania (UNICT). Questo evento ha rappresentato una straordinaria opportunità per Mimesis S.r.l. e il nostro team di ricerca di condividere il nostro lavoro innovativo e i progressi compiuti nell’ambito delle simulazioni in silico. Un’opportunità unica per Mimesis Partecipare al Piaceri Day 2024 è stato un grande onore per noi. Durante la giornata, abbiamo avuto l’occasione di presentare i nostri progetti più recenti e di discutere le future direzioni del nostro lavoro con colleghi, accademici e altri professionisti del settore. Questo evento ci ha permesso di mettere in mostra le capacità e l’impegno del nostro gruppo di ricerca, nonché di tutto il Dipartimento di Scienze del Farmaco e della Salute dell’Università di Catania. Ringraziamenti e Prospettive Future Vogliamo ringraziare tutti coloro che hanno partecipato al Piaceri Day 2024 e che hanno contribuito a rendere questa giornata un successo. Il supporto e l’interesse dimostrati nei confronti del nostro lavoro sono stati fonte di grande ispirazione per tutto il team di Mimesis. Guardando al futuro, siamo determinati a continuare a innovare e a sviluppare nuove tecnologie in grado di trasformare il panorama della salute e del benessere. Il Piaceri Day 2024 ha rappresentato un importante passo avanti nel nostro percorso e siamo entusiasti di vedere dove ci porteranno le nostre prossime ricerche. Rimanete sintonizzati per ulteriori aggiornamenti e per scoprire le prossime tappe del nostro viaggio!

We’re excited to share that our research team at the University of Catania is front and center in #UnictMagazine with our latest groundbreaking study on the #JollyVaccine! In this pioneering investigation, we’ve dedicated ourselves to crafting an innovative solution to address the complexities surrounding vaccination, specifically focusing on the concept of a “Jolly Vaccine.” This initiative has garnered attention from both within and outside the scientific community, as it holds the promise of significantly advancing preventive medicine. Our methodology integrates state-of-the-art technologies with a profound understanding of immunological science, with the goal of surpassing the limitations associated with conventional seasonal vaccines. The #JollyVaccine aims to provide broader and longer-lasting protection against a diverse array of pathogens, thereby enabling enhanced adaptability in managing health crises and bolstering resilience against potential future threats. This study underscores the University of Catania’s unwavering commitment to fostering innovation and excellence in scientific inquiry, thereby contributing to global well-being and health security. We extend our gratitude to all who have supported and contributed to this achievement, and we eagerly anticipate sharing further updates on the progress of our research. Here’s the link to the article: https://www.unictmagazine.unict.it/simulare-il-sistema-immunitario-sviluppare-un-vaccino-influenzale-universale?fbclid=IwAR2eVfK8qrGGn1spHqbnE1m4QFHUu3-5VFHLA3lc5OjwnsYL6PaR1UbBEsg&sfnsn=scwspwa